Prenetics director receives 2,000 shares from stock grant
The director reported 10,001 Class A ordinary shares and 14,003 RSUs after the transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Prenetics Global Ltd director Hudson Blake Leogrande reported the settlement of 2,000 vested restricted stock units on November 4, 2026, with 2,000 Class A ordinary shares issued and delivered under the 2022 Share Incentive Plan. The RSUs vested on June 4, 2026. After the transaction, he reported directly holding 10,001 Class A ordinary shares and 14,003 RSUs.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Share, par value $0.0015 per share F1 | 2,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents 2,000 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan.
- F2. Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. The 2,000 RSUs vested on June 4, 2026.
Key Figures
Key Terms
Restricted Stock Unit financial
settlement financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did each of Hudson Blake Leogrande's RSUs represent, and when did they vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.